Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access, biweekly journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing OncoTarget.
From January 1, 2021 Oncotarget is a biweekly journal that is published on Tuesday.
Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.
Impact Journals meets the Wellcome Trust Publisher Requirements, and is now a member of the Wellcome Trust List of Compliant Publishers.
Impact Journals is a member of the Society for Scholarly Publishing.
PDF | How to cite | Order a Reprint
Metrics: PDF 991 views | ?
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.